Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Wrigley

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|April 1, 1988
Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphomaM A Richards, J A Webb, S E Jewell, et al.
British Journal of Cancer|December 1, 1990
Phase II trial of UFT in advanced colorectal and gastric cancerS T Malik, D Talbot, P I Clarke, et al.
Hematological Oncology|October 1, 1984
The management of localized, infradiaphragmatic Hodgkin's disease: experience of a rare clinical presentation at St Bartholomew's HospitalM S Dorreen, P F Wrigley, A E Jones, et al.
British Journal of Cancer|April 1, 1988
Low field strength magnetic resonance imaging of the spleen: results from volunteers and patients with lymphomaM A Richards, J A Webb, S E Jewell, et al.
Human & Experimental Toxicology|July 1, 1992
Indomethacin and protein binding of methotrexateR Raveendran, W Heybroek, M Caulfield, et al.
Hematological Oncology|April 1, 1987
OPEC chemotherapy (vincristine, prednisolone, etoposide and chlorambucil) for refractory and recurrent Hodgkin's diseaseM J Barnett, A M Man, M A Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
The treatment of stage IIIA Hodgkin's disease--total nodal irradiation versus combination chemotherapy: either or neitherA M Oza, M Leahy, J Lim, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observationM L Slevin, S P Joel, R Whomsley, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycleV J Harvey, M L Slevin, R C Woollard, et al.
British Medical Journal|August 30, 1980
Comparison of two combination chemotherapy regimens in advanced colorectal cancerA A Epenetos, C Amos, C Collis, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|April 1, 1988
Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphomaM A Richards, J A Webb, S E Jewell, et al.
British Journal of Cancer|December 1, 1990
Phase II trial of UFT in advanced colorectal and gastric cancerS T Malik, D Talbot, P I Clarke, et al.
Hematological Oncology|October 1, 1984
The management of localized, infradiaphragmatic Hodgkin's disease: experience of a rare clinical presentation at St Bartholomew's HospitalM S Dorreen, P F Wrigley, A E Jones, et al.
British Journal of Cancer|April 1, 1988
Low field strength magnetic resonance imaging of the spleen: results from volunteers and patients with lymphomaM A Richards, J A Webb, S E Jewell, et al.
Human & Experimental Toxicology|July 1, 1992
Indomethacin and protein binding of methotrexateR Raveendran, W Heybroek, M Caulfield, et al.
Hematological Oncology|April 1, 1987
OPEC chemotherapy (vincristine, prednisolone, etoposide and chlorambucil) for refractory and recurrent Hodgkin's diseaseM J Barnett, A M Man, M A Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
The treatment of stage IIIA Hodgkin's disease--total nodal irradiation versus combination chemotherapy: either or neitherA M Oza, M Leahy, J Lim, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observationM L Slevin, S P Joel, R Whomsley, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycleV J Harvey, M L Slevin, R C Woollard, et al.
British Medical Journal|August 30, 1980
Comparison of two combination chemotherapy regimens in advanced colorectal cancerA A Epenetos, C Amos, C Collis, et al.
Pageof 9